202 related articles for article (PubMed ID: 19334620)
21. 5-Hydroxytryptamine-2A receptor gene (HTR 2 A) candidate polymorphism (T 102 C): Role for human platelet function under pharmacological challenge ex vivo.
Ozdener F; Gülbas Z; Erol K; Ozdemir V
Methods Find Exp Clin Pharmacol; 2005; 27(6):395-400. PubMed ID: 16179957
[TBL] [Abstract][Full Text] [Related]
22. Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3.
Storey RF; Melissa Thornton S; Lawrance R; Husted S; Wickens M; Emanuelsson H; Cannon CP; Heptinstall S; Armstrong M
Platelets; 2009 Aug; 20(5):341-8. PubMed ID: 19637098
[TBL] [Abstract][Full Text] [Related]
23. Increased platelet purinergic sensitivity in peripheral arterial disease--a pilot study.
Braun OO; Jagroop A; Wang L; Mikhailidis DP; Burnstock G; Erlinge D
Platelets; 2005 Aug; 16(5):261-7. PubMed ID: 16011976
[TBL] [Abstract][Full Text] [Related]
24. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (II): pharmacodynamic and pharmacokinetic characterization.
Post JM; Alexander S; Wang YX; Vincelette J; Vergona R; Kent L; Bryant J; Sullivan ME; Dole WP; Morser J; Subramanyam B
Thromb Res; 2008; 122(4):533-40. PubMed ID: 18539312
[TBL] [Abstract][Full Text] [Related]
25. Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): in vitro effects on platelets.
Bryant J; Post JM; Alexander S; Wang YX; Kent L; Schirm S; Tseng JL; Subramanyam B; Buckman B; Islam I; Yuan S; Sullivan ME; Snider M; Morser J
Thromb Res; 2008; 122(4):523-32. PubMed ID: 18495218
[TBL] [Abstract][Full Text] [Related]
26. Identification of P2Y12 single-nucleotide polymorphisms and their influences on the variation in ADP-induced platelet aggregation.
Lee SJ; Jung IS; Jung EJ; Choi JY; Yeo CW; Cho DY; Kim YW; Lee SS; Shin JG
Thromb Res; 2011 Mar; 127(3):220-7. PubMed ID: 21216445
[TBL] [Abstract][Full Text] [Related]
27. Association between platelet P2Y12 haplotype and risk of cardiovascular events in chronic coronary disease.
Schettert IT; Pereira AC; Lopes NH; Hueb WA; Krieger JE
Thromb Res; 2006; 118(6):679-83. PubMed ID: 16405973
[TBL] [Abstract][Full Text] [Related]
28. Shear-induced global thrombosis test of native blood: pivotal role of ADP allows monitoring of P2Y12 antagonist therapy.
Saraf S; Wellsted D; Sharma S; Gorog DA
Thromb Res; 2009 Sep; 124(4):447-51. PubMed ID: 19476973
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of the platelet glycoprotein IIIa Pl(A1/A2) polymorphism in three South African ethnic groups and its effect on platelet function.
Naran NH; Chetty N; Crowther NJ
Thromb Res; 2008; 123(2):316-23. PubMed ID: 18657307
[TBL] [Abstract][Full Text] [Related]
30. Molecular modeling of purinergic receptor P2Y12 and interaction with its antagonists.
Zhan C; Yang J; Dong XC; Wang YL
J Mol Graph Model; 2007 Jul; 26(1):20-31. PubMed ID: 17110146
[TBL] [Abstract][Full Text] [Related]
31. Association between P2Y1 and P2Y12 polymorphisms and acute myocardial infarction and ADP-induced platelet aggregation.
Su C; Zhang Z; Chen J; Tian M; Wu C; Zhang T
BMC Cardiovasc Disord; 2023 Jan; 23(1):41. PubMed ID: 36681816
[TBL] [Abstract][Full Text] [Related]
32. Aspirin resistance and a single gene.
Jefferson BK; Foster JH; McCarthy JJ; Ginsburg G; Parker A; Kottke-Marchant K; Topol EJ
Am J Cardiol; 2005 Mar; 95(6):805-8. PubMed ID: 15757620
[TBL] [Abstract][Full Text] [Related]
33. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
Gachet C
Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
[TBL] [Abstract][Full Text] [Related]
34. Platelet reactivity and endothelial function in children of patients with early acute myocardial infarction.
Lanza GA; Scalone G; Barone L; Infusino F; Coviello I; Di Monaco A; Delogu A; Battipaglia I; De Nisco A; Sestito A; Romagnoli C; Crea F
Eur Heart J; 2011 Aug; 32(16):2042-9. PubMed ID: 21565849
[TBL] [Abstract][Full Text] [Related]
35. The influence of P2Y12 receptor deficiency on the platelet inhibitory activities of prasugrel in a mouse model: evidence for specific inhibition of P2Y12 receptors by prasugrel.
Hashimoto M; Sugidachi A; Isobe T; Niitsu Y; Ogawa T; Jakubowski JA; Asai F
Biochem Pharmacol; 2007 Oct; 74(7):1003-9. PubMed ID: 17681285
[TBL] [Abstract][Full Text] [Related]
36. ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels.
Wihlborg AK; Wang L; Braun OO; Eyjolfsson A; Gustafsson R; Gudbjartsson T; Erlinge D
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1810-5. PubMed ID: 15308557
[TBL] [Abstract][Full Text] [Related]
37. Missense mutation of exon 3 in the type A human natriuretic peptide receptor gene is associated with myocardial infarction.
Nakayama T; Soma M; Saito S; Honye J; Sato M; Aoi N; Kosuge K; Haketa A; Kanmatsuse K; Kokubun S
Med Sci Monit; 2003 Dec; 9(12):CR505-10. PubMed ID: 14646971
[TBL] [Abstract][Full Text] [Related]
38. KCNJ11 polymorphisms and sudden cardiac death in patients with acute myocardial infarction.
Jeron A; Hengstenberg C; Holmer S; Wollnik B; Riegger GA; Schunkert H; Erdmann J
J Mol Cell Cardiol; 2004 Feb; 36(2):287-93. PubMed ID: 14871556
[TBL] [Abstract][Full Text] [Related]
39. Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation.
Molica F; Morel S; Meens MJ; Denis JF; Bradfield PF; Penuela S; Zufferey A; Monyer H; Imhof BA; Chanson M; Laird DW; Fontana P; Kwak BR
Thromb Haemost; 2015 Aug; 114(2):325-36. PubMed ID: 25947940
[TBL] [Abstract][Full Text] [Related]
40. Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy.
Bal Dit Sollier C; Berge N; Boval B; Hovsepian L; Drouet L
Thromb Haemost; 2009 Jan; 101(1):116-22. PubMed ID: 19132197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
